Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 2/2016

Content (22 Articles)

Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13

Yosef Kalish, Amihai Rottenstreich, Deborah Rund, Sarit Hochberg-Klein

Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors

Christoph B. Olivier, Patrick Weik, Melanie Meyer, Susanne Weber, Philipp Diehl, Christoph Bode, Martin Moser, Qian Zhou

Novel oral anticoagulants for heparin-induced thrombocytopenia

Jessica W. Skelley, Jeffrey A. Kyle, Rachel A. Roberts

Intravenous heparin dosing strategy in hospitalized patients with atrial dysrhythmias

Robert O. Roswell, Brian Greet, Sunny Shah, Samuel Bernard, Alexandra Milin, Iryna Lobach, Yu Guo, Martha J. Radford, Jeffrey S. Berger

Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study

Jaya Chandrasekhar, Usman Baber, Roxana Mehran, Melissa Aquino, Samantha Sartori, Jennifer Yu, Annapoorna Kini, Samin Sharma, Carsten Skurk, Richard A. Shlofmitz, Bernhard Witzenbichler, George Dangas

Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial

Sebastian Werth, Rupert Bauersachs, Horst Gerlach, Eberhard Rabe, Sebastian Schellong, Jan Beyer-Westendorf

Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC–MS/MS method

Wan-li Zhang, Dan Lou, Dong-tao Zhang, Yin Zhang, Huan-jie Huang

Open Access

Fibrin structure in organized thrombotic material removed during pulmonary artery endarterectormy: the effect of vessel calibre

Piotr Mazur, Bogusław Gawęda, Joanna Natorska, Michał Ząbczyk, Anetta Undas, Jerzy Sadowski, Grzegorz Kopeć, Marcin Waligóra, Piotr Podolec, Bogusław Kapelak

Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis

Plinio Cirillo, Stefano Conte, Grazia Pellegrino, Francesca Ziviello, Giusi Barra, Raffaele De Palma, Antonio Leonardi, Bruno Trimarco

Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy

Monica Verdoia, Patrizia Pergolini, Matteo Nardin, Roberta Rolla, Lucia Barbieri, Alon Schaffer, Paolo Marino, Giorgio Bellomo, Harry Suryapranata, Giuseppe De Luca

Dual pathway therapy in acute coronary syndrome

Peter Stachon, Ingo Ahrens, Christoph Bode, Andreas Zirlik

Thromboembolic events in patients with severe inherited fibrinogen deficiency

Amihai Rottenstreich, Avigal Lask, Lilliana Schliamser, Ariella Zivelin, Uri Seligsohn, Yosef Kalish

Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience

Kelsey Klute, Ersilia M. DeFilippis, Kelissa Shillingford, John Chapin, Maria T. DeSancho

Severity and outcomes according to stroke etiology in patients under 50 years of age with ischemic stroke

Daniel Prefasi, Patricia Martínez-Sánchez, Blanca Fuentes, Exuperio Díez-Tejedor

Letter to the Editor

In dubious battle: bleeding versus ischemic events

L. Bonello, M. Laine, C. Frere

Open Access Erratum

Erratum to: Pharmacology of anticoagulants used in the treatment of venous thromboembolism

Edith A. Nutescu, Allison Burnett, John Fanikos, Sarah Spinler, Ann Wittkowsky

Erratum

Erratum to: Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review

Jeffrey B. Washam, Rowena J. Dolor, W. Schuyler Jones, Sharif A. Halim, Victor Hasselblad, Stephanie B. Mayer, Brooke L. Heidenfelder, Chiara Melloni

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.